摘要
目的探讨血小板Ⅱb/Ⅲa受体拮抗剂——替罗非班(欣维宁)联合药物洗脱支架治疗急性心肌梗死(AMI)的安全性和有效性。方法因AMI行经皮腔内冠状动脉介入(PCI)治疗的患者52例,于置入药物洗脱支架前予国产替罗非班(欣维宁)负荷量后,以维持量持续静脉泵入48h,观察手术成功率、围手术期出血血栓并发症及1~3个月的主要心脏不良事件(包括死亡,靶血管再次重建术)和出血发生。结果52例患者PCI均取得成功,手术成功率100%,无严重出血并发症,无急性、亚急性血栓及慢血流发生。治疗无死亡,无再发心梗及靶血管再次血运重建,围手术期血小板聚集率明显降低。结论欣维宁联合药物洗脱支架行急诊PCI治疗急性心肌梗死安全有效,不增加出血危险性,可明显降低围手术期及近期并发症。
Objective To evaluate the safety and efficiency of homemade tirofiban combined with drug-eluting stent in the treatment of acute myocardial infarction. Methods Fifty-two cases of myocardial infarction patients were used the load dose homemade tirofiban (Xinweining) before the pereutanenous coronary interventions ( PCI ), then pumped for 48 hours with the sustaining dose. The success rate of operations, peri-operational bleeding and thrombosis complications and main adverse cardiac events were observed, the platelet aggregation rate was monitored. Results Fifty-two patients were all performed PCI successfully, the success rate of operation was 100 %, there were no serious bleeding complications, acute or subaeute intra-stent thrombosis and slow reflow phenomenon occurred. There were no re-infarction and target vascular reperfusion occurred. The platelet aggregation rate were obviously decreased during peri-operation. Conclusion Homemade tirofiban combined with drug-eluting stent, which is safety and efficiency in the treatment of acute myocardial infarction, can obviously decrease the complications of perioperation and short term.
出处
《中国基层医药》
CAS
2007年第2期205-206,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
心肌梗死
血管成形术
经腔
经皮冠状动脉
替罗非班
支架
Myocardial infarction
Angioplasty, transluminal, pereutanenous coronary
Tirofiban
Stents